| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |